GlassScriptPhysician profile
Elie Schochet
NPI 1841463130
$95,906.20
in general payments reported to CMS, 2019-2025
13 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,634 · 2020: $238 · 2021: $7,302 · 2022: $14K · 2023: $40K · 2024: $23K · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $25K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $23K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $2,628 · Travel and Lodging: $1,750 · Gift: $11.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $25,000.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $22,742.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,123.32 |
| Food and Beverage | $2,627.53 |
| Travel and Lodging | $1,749.62 |
| Gift | $11.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Napo Pharmaceuticals INC | $60,942.13 | 2019-2025 | Mytesi |
| Intuitive Surgical, INC. | $30,372.73 | 2022-2023 | Davinci Xi, Da Vinci Surgical System |
| Tela Bio, INC. | $2,087.55 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Thd America, INC. | $1,322.09 | 2019-2023 | |
| Medical Device Business Services, INC. | $227.31 | 2019 | |
| Biom'Up Sa | $196.12 | 2019 | |
| Stryker Corporation | $160.34 | 2025 | Flowtriever |
| W. L. Gore & Associates, INC. | $158.69 | 2025 | Gore Tag Conformable Thoracic Endoprosthesis |
| Boston Scientific Corporation | $144.91 | 2024 | Spyglass Discover |
| Davol INC. | $139.97 | 2024 | Phasix Mesh |
| Ethicon US, LLC | $127.31 | 2019-2020 | |
| Cook Medical LLC | $14.21 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $12.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elie Schochet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.